The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

EuroIntervention 2013;9:546-554. DOI: 10.4244/EIJV9I5A90

1. Medical Research Center of Guangdong General Hospital, Guangzhou, Guangdong, China; 2. Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China; 3. Sun Yat-sen M

Aims: Antiplatelet treatment can cause a change in plasma levels of platelet microRNAs (miRNAs). However, it is not clear whether the plasma level of platelet miRNAs can predict clinical

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique

Latest news